German Diabetes-Diet-Intervention and Energy Restriction-Trial (DDIET) (DDIET)

June 2, 2023 updated by: German Diabetes Center

Short Term Diet Intervention in Newly Diagnosed Type 2 Diabetes. a Randomised, Multicentric, Controlled, Clinical Trial

Diet intervention according to the German Diabetes Risk Score in newly diagnosed type 2 diabetes.

This study aims to explore the effect of diet lacking red meat, but containing increased fibers and coffee (verum) versus standard recommendation (control) in a multicenter setting.

Study Overview

Status

Completed

Conditions

Detailed Description

This study is a randomised, multicenter controlled trial Our Aim is to test the effects of an 8-week diet lacking red meat, containing increased fibers and coffee (verum) versus standard recommendation (control)in a multicenter setting.

We are expecting that the verum diet will improve insulin sensitivity and insulin secretion due to reductions in visceral and hepatic fat along with improved adipocyte cytokine secretion profiles

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Berlin, Germany
        • Charite, Department of Internal Medicine
      • Dresden, Germany
        • University Hospital, Department of Internal Medicine III
      • Heidelberg, Germany
        • University Hospital, Department of Internal Medicine I
      • Munich, Germany
        • Klinikum der Universität München (KUM)
      • Tübingen, Germany
        • University Hospital, Department of Internal Medicine IV
    • NRW
      • Duesseldorf, NRW, Germany, 40225
        • German Diabetes Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 69 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Type 2 diabetic patients
  • disease duration for five years or less,
  • age of 69 years or less,
  • body mass index of 30 kg/m2 or more,
  • hemoglobin A1c of 5,5 % to 9%
  • patient should be on standard diet or metformin +/- acarbose monotherapy
  • patient should be without exclusion criteria for coffee consumption

Exclusion Criteria:

  • disease duration more than five years,
  • age of > 69 years,
  • body mass index of < 30 kg/m2,
  • hemoglobin A1c < 5,5 % or > 9%
  • if patient becomes insulin therapy
  • if patient has exclusion criteria for coffee consumption
  • if patient is non-compliant with study protocol
  • if patient is pregnant
  • if patient has acute infection
  • if patient has anaemia
  • if patient has malignancies
  • if patient has autoimmune or immune compromising diseases including HIV/AIDS
  • if patient has psychiatric diseases or addiction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: hypocaloric diet containing increased fibers and coffee
In the intervention group the patients are allowed to eat only white meat and fish. They also need to increase their daily fiber intake to 50grams and drink 5 cups of coffee a day.
8-week diet lacking red meat, but containing increased fibers and coffee (verum) versus standard recommendation (control) eating red meat.
Active Comparator: hypocaloric diet containing red meat
control group (n=20): diet according to the ADA/EASD guidelines (50% carbohydrates, 20% proteins, 30% fat). In the control group the patients should eat 150 grams of red meat a day and are not allowed to consume alcohol, coffee and whole grains.
8-week diet lacking red meat, but containing increased fibers and coffee (verum) versus standard recommendation (control) eating red meat.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
whole body insulin sensitivity
Time Frame: 8 weeks
measurement of whole body insulin sensitivity with hyperinsulinamic euglicamic clamp
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
total body fat
Time Frame: 8 weeks
MRI measurement of the effects of 8-week diet intervention on total body fat
8 weeks
intramyocellular lipids
Time Frame: 8 weeks
MRS measurement to investigate the effects of diet intervention on ectopic lipid content in skeletal muscle
8 weeks
hepatocellular lipids
Time Frame: 8 weeks
MRS measurement to investigate the effects of diet intervention on ectopic lipid content in liver(HCL)
8 weeks
insulin secretion
Time Frame: 8 weeks
measurement of insulin secretion with glucagon test, mixed-meal test and intravenous glucose tolerance test
8 weeks
pancreatic fat
Time Frame: 8 weeks
MRI measurement of the effects of 8-week diet intervention on pancreatic fat
8 weeks
skeletal muscle mitochondrial function - insulin signaling
Time Frame: 8 weeks
muscle biopsy for assessment of insulin signaling
8 weeks
skeletal muscle mitochondrial function - phosphate-recovery time
Time Frame: 8 weeks
skeletal muscle mitochondrial function in vivo assessed as phosphate-recovery time with MRS
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Michael Roden, MD, German Diabetes Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2011

Primary Completion (Actual)

September 1, 2013

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

June 8, 2011

First Submitted That Met QC Criteria

August 3, 2011

First Posted (Estimated)

August 4, 2011

Study Record Updates

Last Update Posted (Actual)

June 5, 2023

Last Update Submitted That Met QC Criteria

June 2, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes

Clinical Trials on diet intervention

3
Subscribe